Abstract
Efficient development of stable formulations of protein pharmaceuticals requires an intimate knowledge of the protein and its chemical and physical properties. In particular, understanding the mechanisms by which a protein could degrade is critical for designing and testing formulations. This review describes the major pathways by which proteins can degrade, including denaturation, aggregation, oxidation, and interfacial damage. The methods to detect the degradation are covered, along with generalized strategies to retard or prevent each type of decomposition. Without an appreciation of the current best practices for devising stable formulations, the formulation process will be neither efficient nor optimal.
Keywords: Protein, Hydrophobic Interactions, Fluorescence Spectroscopy
Current Pharmaceutical Biotechnology
Title: The Stability Factor: Importance in Formulation Development
Volume: 3 Issue: 4
Author(s): Rajesh Krishnamurthy and Mark C. Manning
Affiliation:
Keywords: Protein, Hydrophobic Interactions, Fluorescence Spectroscopy
Abstract: Efficient development of stable formulations of protein pharmaceuticals requires an intimate knowledge of the protein and its chemical and physical properties. In particular, understanding the mechanisms by which a protein could degrade is critical for designing and testing formulations. This review describes the major pathways by which proteins can degrade, including denaturation, aggregation, oxidation, and interfacial damage. The methods to detect the degradation are covered, along with generalized strategies to retard or prevent each type of decomposition. Without an appreciation of the current best practices for devising stable formulations, the formulation process will be neither efficient nor optimal.
Export Options
About this article
Cite this article as:
Krishnamurthy Rajesh and Manning C. Mark, The Stability Factor: Importance in Formulation Development, Current Pharmaceutical Biotechnology 2002; 3 (4) . https://dx.doi.org/10.2174/1389201023378229
DOI https://dx.doi.org/10.2174/1389201023378229 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MicroRNAs and Stem Cells to the Rescue
Current Neurovascular Research Desensitization for Drug Hypersensitivity to Chemotherapy and Monoclonal Antibodies
Current Pharmaceutical Design Trends in Snakebite Envenomation Therapy: Scientific, Technological and Public Health Considerations
Current Pharmaceutical Design Current and Emerging Therapies in Primary Myelofibrosis
Cardiovascular & Hematological Disorders-Drug Targets Neurogenic Drugs and Compounds
Recent Patents on CNS Drug Discovery (Discontinued) A Role for the Inflammatory Mediators Cox-2 and Metalloproteinases in Cancer Stemness
Anti-Cancer Agents in Medicinal Chemistry Tachykinins in the Immune System
Current Drug Targets Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Current Pharmaceutical Design Review: New Anti-Cytokines for IBD: What is in the Pipeline?
Current Drug Targets Non-Systemic Drugs: A Critical Review
Current Pharmaceutical Design The Bioartificial Kidney in the Treatment of Acute Kidney Injury
Current Drug Targets Acknowledgements to Reviewers:
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Transforming Growth Factor Beta in Pancreatic Cancer
Current Pharmaceutical Biotechnology Other Activities
Current Bioactive Compounds Glucans as Biological Response Modifiers
Endocrine, Metabolic & Immune Disorders - Drug Targets Accumulation of Vincristine in Calcium Chloride Elicitated Catharanthus roseus Cultures
The Natural Products Journal Granulocyte Colony-Stimulating Factor (G-CSF) in the Mechanism of Human Ovulation and its Clinical Usefulness
Current Medicinal Chemistry Recent Advances in Management of Diabetic Macular Edema
Current Diabetes Reviews Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
Current Drug Targets